INBX Recorded Big Gain
Tue, Oct 12, 2021 at 05:30 PM
INBX (INBX:NASDAQ) soared at $33.68, a gain of 22%. On Mon, Oct 11, 2021, INBX:NASDAQ touched a New 2-Week Intraday Low of $26.4. The stock appeared on our News Catalysts scanner on Tue, Oct 12, 2021 at 07:39 AM in the 'BIOTECH' category. From Mon, Sep 27, 2021, the stock recorded 10.00% Up Days and 9.09% Green Days
About INBX (INBX:NASDAQ)
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates.
Top 10 Gainers:
- GWH (GWH:NYSE), 128.41%
- PONO (PONO:NASDAQ), 86.57%
- NRXP (NRXP:NASDAQ), 61.06%
- R. R. Donnelley & Sons Company (RRD:NYSE), 33.27%
- Tiptree Inc. (TIPT:NASDAQ), 32.28%
- Koss Corporation (KOSS:NASDAQ), 24.95%
- INBX (INBX:NASDAQ), 21.98%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 20.42%
- Cabot Oil & Gas Corporation (COG:NYSE), 20.08%
- BBIG (BBIG:NASDAQ), 19.89%